Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

The role of clofarabine in acute myeloid leukemia.

Ghanem H, Kantarjian H, Ohanian M, Jabbour E.

Leuk Lymphoma. 2013 Apr;54(4):688-98. doi: 10.3109/10428194.2012.726722. Epub 2012 Sep 28. Review.

PMID:
22957815
2.

Clofarabine in leukemia.

Ghanem H, Jabbour E, Faderl S, Ghandhi V, Plunkett W, Kantarjian H.

Expert Rev Hematol. 2010 Feb;3(1):15-22. doi: 10.1586/ehm.09.70. Review.

PMID:
21082931
3.

The role of clofarabine in hematologic and solid malignancies--development of a next-generation nucleoside analog.

Faderl S, Gandhi V, Keating MJ, Jeha S, Plunkett W, Kantarjian HM.

Cancer. 2005 May 15;103(10):1985-95. Review.

4.

Clofarabine in the treatment of acute myeloid leukaemia and acute lymphoblastic leukaemia: a review.

Kline JP, Larson RA.

Expert Opin Pharmacother. 2005 Dec;6(15):2711-8. Review.

PMID:
16316309
5.

Clofarabine: emerging role in leukemias.

Sampat K, Kantarjian H, Borthakur G.

Expert Opin Investig Drugs. 2009 Oct;18(10):1559-64. doi: 10.1517/13543780903173222.

PMID:
19715446
6.
7.

Clofarabine in the treatment of newly diagnosed acute myeloid leukemia in older adults.

Tran H, Yang D.

Ann Pharmacother. 2012 Jan;46(1):89-96. doi: 10.1345/aph.1Q295. Epub 2011 Dec 13. Review.

PMID:
22170975
8.

Clofarabine: a new treatment option for patients with acute myeloid leukemia.

Larson ML, Venugopal P.

Expert Opin Pharmacother. 2009 Jun;10(8):1353-7. doi: 10.1517/14656560902997990. Review.

PMID:
19463072
9.

Clofarabine in the treatment of myelodysplastic syndromes.

Bryan J, Kantarjian H, Prescott H, Jabbour E.

Expert Opin Investig Drugs. 2014 Feb;23(2):255-63. doi: 10.1517/13543784.2014.877887. Review.

PMID:
24410313
10.

Mechanisms of anti-cancer action and pharmacology of clofarabine.

Zhenchuk A, Lotfi K, Juliusson G, Albertioni F.

Biochem Pharmacol. 2009 Dec 1;78(11):1351-9. doi: 10.1016/j.bcp.2009.06.094. Epub 2009 Jul 1. Review.

PMID:
19576186
11.

The role of Clofarabine in the treatment of adults with acute myeloid leukemia.

Fozza C.

Crit Rev Oncol Hematol. 2015 Mar;93(3):237-45. doi: 10.1016/j.critrevonc.2014.10.009. Epub 2014 Oct 22. Review.

PMID:
25457773
12.

Clofarabine.

[No authors listed]

Drugs R D. 2004;5(4):213-7. Review.

PMID:
15230627
13.

Clofarabine for the treatment of adult acute myeloid leukemia.

Thomas X, Raffoux E, Elhamri M, Lobe I, Cannas G, Dombret H.

Future Oncol. 2009 Oct;5(8):1197-210. doi: 10.2217/fon.09.105. Review.

PMID:
19852733
14.

Clofarabine: past, present, and future.

Kantarjian HM, Jeha S, Gandhi V, Wess M, Faderl S.

Leuk Lymphoma. 2007 Oct;48(10):1922-30. Review.

PMID:
17852710
15.

Clofarabine does not negatively impact the outcomes of patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation.

Mathisen MS, Kantarjian H, Jabbour E, Garcia-Manero G, Ravandi F, Faderl S, Borthakur G, Cortes JE, Quintás-Cardama A.

Clin Lymphoma Myeloma Leuk. 2013 Apr;13(2):139-43. doi: 10.1016/j.clml.2012.11.004. Epub 2012 Dec 29.

16.

Clofarabine in pediatric acute leukemia: current findings and issues.

Hijiya N, Barry E, Arceci RJ.

Pediatr Blood Cancer. 2012 Sep;59(3):417-22. doi: 10.1002/pbc.24112. Epub 2012 Feb 21. Review.

PMID:
22354543
17.

Treatment of molecular relapse in patients with acute myeloid leukemia using clofarabine monotherapy.

Racil Z, Toskova M, Dvorakova D, Jeziskova I, Razga F, Buresova L, Timilsina S, Mayer J.

Am J Hematol. 2012 Feb;87(2):211-3. doi: 10.1002/ajh.22213. Epub 2011 Nov 4.

18.

Clofarabine, idarubicin, and cytarabine (CIA) as frontline therapy for patients ≤60 years with newly diagnosed acute myeloid leukemia.

Nazha A, Kantarjian H, Ravandi F, Huang X, Choi S, Garcia-Manero G, Jabbour E, Borthakur G, Kadia T, Konopleva M, Cortes J, Ferrajoli A, Kornblau S, Daver N, Pemmaraju N, Andreeff M, Estrov Z, Du M, Brandt M, Faderl S.

Am J Hematol. 2013 Nov;88(11):961-6. doi: 10.1002/ajh.23544. Epub 2013 Sep 9.

19.

European development of clofarabine as treatment for older patients with acute myeloid leukemia considered unsuitable for intensive chemotherapy.

Burnett AK, Russell NH, Kell J, Dennis M, Milligan D, Paolini S, Yin J, Culligan D, Johnston P, Murphy J, McMullin MF, Hunter A, Das-Gupta E, Clark R, Carr R, Hills RK.

J Clin Oncol. 2010 May 10;28(14):2389-95. doi: 10.1200/JCO.2009.26.4242. Epub 2010 Apr 12.

PMID:
20385984
20.

Clofarabine for myelodysplastic syndromes.

Tiu RV, Traina F, Sekeres MA.

Expert Opin Investig Drugs. 2011 Jul;20(7):1005-14. doi: 10.1517/13543784.2011.585967. Epub 2011 May 19. Review.

PMID:
21591997

Supplemental Content

Support Center